Willow Biosciences (WLLW) Stock Price, News & Analysis

Company Overview

Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company has a collaboration agreement with SUANFARMA to develop anti-infective API through precision fermentation. Willow Biosciences Inc. is headquartered in Calgary, Canada.

Key Stats

• Today's Range: C$0.06 to C$0.06
• 50-Day Range: C$0.06 to C$0.10
• 52-Week Range: C$0.06 to C$0.15
• Volume: 129,000 shs
• Average Volume: 89,770 shs
• Market Capitalization: C$7.93 million
• P/E Ratio: N/A
• Dividend Yield: 7.35%
• Price Target: N/A
• Consensus Rating: N/A

WLLW Stock Analysis - Frequently Asked Questions

How have WLLW shares performed this year?

Willow Biosciences' stock was trading at C$0.10 on January 1st, 2024. Since then, WLLW shares have decreased by 45.0% and is now trading at C$0.06.
View the best growth stocks for 2024 here.

How do I buy shares of Willow Biosciences?

Shares of WLLW stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What other stocks do shareholders of Willow Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Willow Biosciences investors own include Canopy Growth (CGC), Dynavax Technologies (DVAX), Lightspeed Commerce (LSPD), VEON (VEON), Vaxart (VXRT), BlackBerry (BB) and NightHawk Biosciences (NHWK).

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: TSE:WLLW
• CUSIP: N/A
• CIK: N/A
• Web: www.willowbio.com
• Phone: 403 910 5140
• Fax: N/A
• Employees: 19
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): C($0.06)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 2.86
• P/E Growth: N/A
• Net Income: C$-8,700,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -212.20%
• Return on Assets: -74.79%

Debt

• Debt-to-Equity Ratio: 131.61
• Current Ratio: 0.70
• Quick Ratio: 19.71

Sales & Book Value

• Annual Sales: C$1.84 million
• Price / Sales: 4.31
• Cash Flow: C$0.07 per share
• Price / Cash Flow: 0.83
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 144,200,000
• Free Float: N/A
• Market Cap: C$7.93 million
• Optionable: Not Optionable
• Beta: 1.13